Screen Culture
Corporate Culture
YouTube Cracks Down on Fake Movie Trailer Channels Making Money
As the AI-generated content clips swarm the platform, action is finally being taken to de-monetize them.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Veteran Boston TV news anchor claims she lost job because she's white
A Boston TV anchor claims in a lawsuit that she was demoted from her job because she's a white woman, alleging she was the supposed victim of a 'DEI agenda' at the Tiffany Network. Katherine Merrill Dunham, better known as Kate Merrill while serving as a longtime anchor for CBS affiliate WBZ-TV, filed a lawsuit against the station's corporate parents CBS and Paramount Global this month, alleging she was booted from the newsroom to appease corporate diversity quotas. The 51-year-old is an Emmy Award-winning broadcaster and is married to former NHL goalie Mike Dunham. She stunned viewers last year when she quit the station without giving viewers an explanation. In her suit, filed in Boston federal court Aug. 5, Merrill alleged that she was targeted by managers who said the morning show was 'too white' and by co-workers who filed 'malicious' race-based complaints against her, per the New York Post. The lawsuit cites exclusive reporting by the New York Post of then-CBS News president Ingrid Ciprian-Matthews, who was accused of using her position of power to promote minorities while sidelining white journalists during her tenure. HANSON: Why DEI was already dying 'THEY'RE NUTS': Kevin O'Leary slams Costco for doubling down on DEI policy Ciprian-Matthews was named as president of CBS News in August 2023 despite being the subject of an internal probe by the company two years earlier over her alleged hiring practices, the Post reported. 'WBZ-TV exploited such policies and took career-ending action against Ms. Merrill to advance a DEI agenda,' according to the complaint. Ciprian-Matthews stepped down last July and Paramount scrapped its DEI programs earlier this year. According to the complaint, the difficulties started when Jason Mikell, a Black co-worker and meteorologist at WBZ, allegedly 'made an inappropriate sexual innuendo about' Merrill 'on air' in February 2024 when he 'implied that Ms. Merrill and her co-anchor had sexual relations at a gazebo.' The lawsuit alleges that despite complaints to supervisors by Merrill's executive producer, Mikell 'was not disciplined for his sexually charged remark about Ms. Merrill.' In April 2024, after she privately texted him to correct a mispronunciation of 'Concord,' Mikell allegedly 'loudly yelled at her on the studio floor,' according to the suit. Merrill claims she quickly complained to human resources; however, a week later, Paramount's HR chief informed her that Mikell and Courtney Cole, a Black anchor hired by WBZ in 2022, had accused her of racial bias. After 20 years at the station, the Emmy-winning broadcaster charges that she was branded a racist, demoted in public and forced into a 'constructive discharge resignation.' RECOMMENDED VIDEO
Yahoo
26 minutes ago
- Yahoo
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
CAMBRIDGE, Mass., Aug. 19, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases. This collaboration will be based on XtalPi's intelligent and automated drug discovery platform, which integrates artificial intelligence (AI), quantum physics, and large-scale automated robotic experiments. The two companies plan to co-identify targets and discover first-in-class or best-in-class drug candidates using XtalPi's proprietary AI-driven drug discovery platform. The XtalPi platform combines the speed and generative power of AI with the accuracy of its robotic lab-in-the-loop to accelerate drug discovery and vastly expand the explorable chemical space. This integrated workflow spans deep-learning-based molecule design, quantum physics and molecular dynamics simulations for predicting drug-target interactions, automated chemical synthesis, and experimental validation of candidate compounds' key pharmaceutical properties. Leveraging its expertise in immunology and inflammation as well as its experience in small molecule drug development, Dong-A ST will actively participate throughout the entire R&D process—including candidate validation, efficacy and safety testing, and the formulation of preclinical and clinical development strategies. The company also plans to explore strategies for pipeline expansion and assess commercialization potential. Through this partnership, Dong-A ST aims to strengthen its pipeline in the immunology and inflammation space and expand its R&D scope beyond small molecule therapeutics into areas such as targeted protein degradation (TPD), biologics, antibody-drug conjugates (ADC), and gene therapies. John Wang, Senior Vice President of Drug Discovery at XtalPi, stated: "The combination of Dong-A ST's extensive expertise and XtalPi's proven AI-robotics platform is well-positioned to translate scientific innovation into competitive precision medicines. Together, we aim to rapidly discover and rigorously validate novel drug candidates across multiple modalities to unlock unique market opportunities, and deliver transformative therapies for global patients." Jae-Hong Park, Head of R&D at Dong-A ST, remarked, "This collaboration marks a pivotal step in expanding Dong-A ST's R&D capabilities," adding, "By leveraging synergies with XtalPi's AI platform, we expect to accelerate the development of next-generation treatments for immune and inflammatory diseases." Meanwhile, both Dong-A ST and XtalPi operate open innovation offices in Boston, USA. This geographic proximity will facilitate closer and more efficient collaboration throughout the drug discovery process. About Dong-A ST Dong-A ST Co., Ltd. ( was established in 1932 and is a leading Korean pharmaceutical company engaged in the development, manufacturing, and commercialization of ethical drugs, biosimilars, medical devices, and diagnostics. Its key products include Stillen (gastritis), Zydena (erectile dysfunction), Motilitone (functional dyspepsia), and Imuldosa (ustekinuma biosimilar). Leveraging strong R&D capabilities and a history of innovation, Dong-A ST is expanding its pipeline in immunology, inflammation, neurological disease, metabolic diseases, and oncology, while advancing into new modalities such as biologics, ADCs, TPD, and gene therapies. About XtalPi XtalPi Holdings Limited (XtalPi, was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries. View original content to download multimedia: SOURCE XtalPi Inc. Sign in to access your portfolio
New York Times
26 minutes ago
- New York Times
Trump's White House Joins TikTok
President Trump has started an official White House account on TikTok, deepening his ties with the Chinese-owned social media company as he repeatedly declines to enforce a federal law that would ban the company's app because of national security concerns. The first post by @WhiteHouse on TikTok — showing Mr. Trump at various events while dramatic music plays — referenced a viral video on the social media site that featured footage from the movie 'Creed' and music by the rapper Kendrick Lamar. The White House's embrace of TikTok continues a remarkable turnabout for Mr. Trump, who tried to ban the platform in his first term. Mr. Trump created a personal account in June 2024, and his popularity on the app soared amid his effort to court TikTok's predominantly younger voters. Donors to Mr. Trump and the company's executives have also undertaken a lobbying effort to prevent TikTok from going dark in the United States. Mr. Trump's return to TikTok — the last post on his personal account was on Election Day — is the latest sign that he has little intention of enforcing the national security ban on the app. The ban stemmed from a 2024 law that requires app stores and cloud computing providers to stop distributing or hosting TikTok unless it is sold by its Chinese parent company, ByteDance. A bipartisan coalition in Congress passed the law over concerns that the Chinese government could use the app to gather information about Americans or spread propaganda. After drawing a devoted following on TikTok that supported his successful re-election bid, the president-elect threw the app an unexpected lifeline in its quest to continue operating in the United States. Hours after the federal law banning the app took effect in the final days of the Biden administration, Mr. Trump said that he would issue an executive order to delay the enforcement of the ban. The law has a section allowing Mr. Trump to grant a 90-day extension if a buyer is found, but only if there is 'significant progress' toward a deal that puts TikTok in the hands of a non-Chinese company. Mr. Trump made several additional extensions anyway. TikTok has until mid-September to find a new owner, but Mr. Trump could grant another extension.
